Kevin Kulshrestha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kevin Kulshrestha has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- David Luis Simon Morales
University of Cincinnati College of Medicine
5 shared publications - Awais Ashfaq
University of Cincinnati College of Medicine
4 shared publications - Farhan Zafar
Department of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
4 shared publications David L.S. Morales
Division of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Heart Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio
3 shared publicationsFarhan Zafar
Division of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Heart Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio
3 shared publications- Hosam F. Ahmed
NYU Langone Health New York City New York USA
3 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (12) , e1357
National Experience With Tracheostomy in Neonates Undergoing Congenital Heart Surgery: A Multicenter Analysis
OBJECTIVES: Our aim was to describe trends in tracheostomy utilization in infants requiring congenital heart surgery (CHS) during their index admission with specific focus on clinical and financial outcomes. DESIGN: A retrospective cohort study. SETTING: Data were obtained from the Pediatric Health Information System database. PATIENTS: Patients admitted as neonates (≤ 28 d) undergoing CHS with the use of cardiopulmonary bypass (CPB) during admission from 2004 to 2022 were identified. The cohort was divided into patients with vs. without tracheostomy. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We identified 13,415 neonatal admissions who underwent CHS with use of CPB, of which 391 (3%) underwent tracheostomy. Tracheostomy patients, compared with those without, were more likely to be female (46.8% vs. 40.0%; p = 0.007), of Black race (17.1% vs. 10.6%), preterm (29.2% vs. 14.1%), low birthweight (29.4% vs. 14.1%), had a higher frequency of chromosomal defects (23.5% vs. 8%), congenital airway (24% vs. 3.3%), and pulmonary (19.7% vs. 1.7%) abnormalities (all p < 0.001). Tracheostomy was associated with higher in-hospital mortality (23.8% vs. 8.6%), longer length of stay (183 vs. 26 d), higher cost of hospitalization ($1.2 vs. $0.2 million), and discharge to a location other than home (35.1% vs. 6.3%; all p < 0.001). Tracheostomy rates increased from 1.9% in 2004–2010 to 3% in 2017–2022 ( p = 0.002), while the in-hospital mortality in these patients was similar ( p = 0.72). CONCLUSIONS: The rate of tracheostomy placement in complex neonates and infants requiring CHS has increased in recent years. Patients with congenital airway or pulmonary abnormalities, cleft lip and/or palate, chromosomal disorders, and those requiring more than one surgery requiring CPB during admission were at greatest risk for tracheostomy placement. Tracheostomy is associated with longer ICU and hospital length of stay, six-fold increase in hospitalization cost, and higher rate of in-hospital mortality in our study population.
- 24 November 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (12) , e1357
Open AccessNational Experience With Tracheostomy in Neonates Undergoing Congenital Heart Surgery: A Multicenter Analysis
OBJECTIVES: Our aim was to describe trends in tracheostomy utilization in infants requiring congenital heart surgery (CHS) during their index admission with specific focus on clinical and financial outcomes. DESIGN: A retrospective cohort study. SETTING: Data were obtained from the Pediatric Health Information System database. PATIENTS: Patients admitted as neonates (≤ 28 d) undergoing CHS with the use of cardiopulmonary bypass (CPB) during admission from 2004 to 2022 were identified. The cohort was divided into patients with vs. without tracheostomy. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We identified 13,415 neonatal admissions who underwent CHS with use of CPB, of which 391 (3%) underwent tracheostomy. Tracheostomy patients, compared with those without, were more likely to be female (46.8% vs. 40.0%; p = 0.007), of Black race (17.1% vs. 10.6%), preterm (29.2% vs. 14.1%), low birthweight (29.4% vs. 14.1%), had a higher frequency of chromosomal defects (23.5% vs. 8%), congenital airway (24% vs. 3.3%), and pulmonary (19.7% vs. 1.7%) abnormalities (all p < 0.001). Tracheostomy was associated with higher in-hospital mortality (23.8% vs. 8.6%), longer length of stay (183 vs. 26 d), higher cost of hospitalization ($1.2 vs. $0.2 million), and discharge to a location other than home (35.1% vs. 6.3%; all p < 0.001). Tracheostomy rates increased from 1.9% in 2004–2010 to 3% in 2017–2022 ( p = 0.002), while the in-hospital mortality in these patients was similar ( p = 0.72). CONCLUSIONS: The rate of tracheostomy placement in complex neonates and infants requiring CHS has increased in recent years. Patients with congenital airway or pulmonary abnormalities, cleft lip and/or palate, chromosomal disorders, and those requiring more than one surgery requiring CPB during admission were at greatest risk for tracheostomy placement. Tracheostomy is associated with longer ICU and hospital length of stay, six-fold increase in hospitalization cost, and higher rate of in-hospital mortality in our study population.
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 112-120
A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation
Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 112-120
A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation
Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.
- 27 September 2023
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 167 (6) , 2193-2203
The majority of pediatric Fontan patients have excellent post-transplant survival
- 27 September 2023
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 167 (6) , 2193-2203
The majority of pediatric Fontan patients have excellent post-transplant survival
- 22 August 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (1) , 32-35
Reality of DCD donor use in pediatric thoracic transplantation in the United States
- 22 August 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (1) , 32-35
Reality of DCD donor use in pediatric thoracic transplantation in the United States
- 27 June 2023
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 167 (2) , 422-430
National experience with pediatric surgical aortic valve repair: A Pediatric Health Information System analysis
- 27 June 2023
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 167 (2) , 422-430
National experience with pediatric surgical aortic valve repair: A Pediatric Health Information System analysis
- 3 June 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (3) , 611-618
Up to an Hour of Donor Resuscitation Does Not Affect Pediatric Heart Transplantation Survival
- 3 June 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (3) , 611-618
Up to an Hour of Donor Resuscitation Does Not Affect Pediatric Heart Transplantation Survival
- 7 November 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14433
Not all durations of preheart transplant mechanical ventilation portend inferior post‐transplant survival in children
Background: Mechanical ventilation prior to pediatric heart transplantation predicts inferior post‐transplant survival, but the impact of ventilation duration on survival is unclear.Methods: Data from the United Network for Organ Sharing and Pediatric Health Information System were used to identify pediatric (5 weeks).Results: At transplant, 11% (511/4506) of patients required ventilation. Ventilated patients were younger, had more congenital heart disease, more urgent listing‐status, and greater rates of nephropathy, TPN‐dependence, and inotrope and ECMO requirements (p < .001 for all). Post‐transplant, previously ventilated patients experienced longer ventilation durations, ICU and hospital stays, and inferior survival (all p < .001). Hospital outcomes and survival worsened with longer pretransplant ventilation. One‐year and overall survival were similar between the no‐ventilation and ≤1 week groups (p = .703 & p = .433, respectively) but were significantly worse for ventilation durations >1 week (p < .001). On multivariable analysis, ventilation ≤1 week did not predict mortality (HR 0.98 [95% CI 0.85–1.43]), whereas ventilation >1 week did (HR: 1.18 [1.01–1.39]).Conclusions: Longer pretransplant ventilation portends worse outcomes, although only ventilation >1 week predicts mortality. These findings can inform pretransplant prognostication.
- 7 November 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14433
Not all durations of preheart transplant mechanical ventilation portend inferior post‐transplant survival in children
Background: Mechanical ventilation prior to pediatric heart transplantation predicts inferior post‐transplant survival, but the impact of ventilation duration on survival is unclear.Methods: Data from the United Network for Organ Sharing and Pediatric Health Information System were used to identify pediatric (5 weeks).Results: At transplant, 11% (511/4506) of patients required ventilation. Ventilated patients were younger, had more congenital heart disease, more urgent listing‐status, and greater rates of nephropathy, TPN‐dependence, and inotrope and ECMO requirements (p < .001 for all). Post‐transplant, previously ventilated patients experienced longer ventilation durations, ICU and hospital stays, and inferior survival (all p < .001). Hospital outcomes and survival worsened with longer pretransplant ventilation. One‐year and overall survival were similar between the no‐ventilation and ≤1 week groups (p = .703 & p = .433, respectively) but were significantly worse for ventilation durations >1 week (p < .001). On multivariable analysis, ventilation ≤1 week did not predict mortality (HR 0.98 [95% CI 0.85–1.43]), whereas ventilation >1 week did (HR: 1.18 [1.01–1.39]).Conclusions: Longer pretransplant ventilation portends worse outcomes, although only ventilation >1 week predicts mortality. These findings can inform pretransplant prognostication.
- 19 October 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (1) , e14414
Female donor hearts can improve survival for male pediatric heart transplant recipients
Background: Both gender‐ and weight‐matching between donor and recipient are thought to impact survival in pediatric heart transplantation, with clinical dogma holding that male donor hearts and “ideal” weight‐matching yield superior survival. The composite impacts of gender and weight on post‐transplant survival (PTS) are understudied.Methods: All pediatric (age p < .001 vs. others) and lowest for undersized DRWR from either male or female donors (median 13.4 and 13.2 years; p < .001 vs. others). The majority (64%) of male recipients received ideal‐sized DRWR, among which female donor hearts yielded superior survival to males (median 18.9 vs. 17.4 years, p = .014). No differences in PTS existed for female recipients on the basis of gender‐match, DRWR, and gender/DRWR together (all p > .1).Conclusions: When considered together, gender and DRWR pairings impact PTS in male—but not female—pediatric heart transplant recipients. For males receiving ideal‐sized DRWR organs (most common pairing, >60%), male recipients achieve superior survival when female donor hearts are transplanted. These findings suggest that if weight is being used for size‐matching, donor gender should also be considered, particularly for male recipients.
- 19 October 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (1) , e14414
Female donor hearts can improve survival for male pediatric heart transplant recipients
Background: Both gender‐ and weight‐matching between donor and recipient are thought to impact survival in pediatric heart transplantation, with clinical dogma holding that male donor hearts and “ideal” weight‐matching yield superior survival. The composite impacts of gender and weight on post‐transplant survival (PTS) are understudied.Methods: All pediatric (age p < .001 vs. others) and lowest for undersized DRWR from either male or female donors (median 13.4 and 13.2 years; p < .001 vs. others). The majority (64%) of male recipients received ideal‐sized DRWR, among which female donor hearts yielded superior survival to males (median 18.9 vs. 17.4 years, p = .014). No differences in PTS existed for female recipients on the basis of gender‐match, DRWR, and gender/DRWR together (all p > .1).Conclusions: When considered together, gender and DRWR pairings impact PTS in male—but not female—pediatric heart transplant recipients. For males receiving ideal‐sized DRWR organs (most common pairing, >60%), male recipients achieve superior survival when female donor hearts are transplanted. These findings suggest that if weight is being used for size‐matching, donor gender should also be considered, particularly for male recipients.